Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Injured in Crash on Interstate 10 Near Citrus Avenue


2 Vehicles Collide in Hit and Run Accident in Fontana

Fontana, CA (April 12, 2020) – One person was injured in a hit and run crash in Fontana. The accident occurred on the afternoon of Interstate 10.

A vehicle hit a Toyota Corolla in the westbound lanes of Interstate 10 at Citrus Avenue. Emergency crews found the Toyota on the right shoulder of the freeway. One occupant of the Toyota suffered injuries in the crash. The other vehicle fled the accident scene.

#Fontana

#92335


November 14, 2019

Man Killed in Crash on Highway 37 Near Fairgrounds Drive

Victim Hit While Crossing Highway in Fatal Vallejo Accident...


October 9, 2019

Diane Castillo Injured in Hit and Run Crash on Vermont Avenue

Beloved Dog Dies in Torrance Accident Torrance, CA (October 7, 2019) – A woma...


April 13, 2020

1 Injured in Crash on Mark West Springs Road

Car Goes Off Embankment in Santa Rosa Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.